Yin Sun

Has grant

Stanford University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Open

Identifying Effective CXCR3 Antagonists to Mitigate Immunotherapy-Induced Myocarditis

Open Date: 2025-01-01

Close Date: 2026-12-31

Articles (10)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (1)

Yuhsin Vivian Huang

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yin Sun

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Novel Therapeutic Approach Targeting CXCR3 to Treat Immunotherapy Myocarditis

Discovery of the First Potent, Selective, and <i>In Vivo</i> Efficacious Polo-like Kinase 4 Proteolysis Targeting Chimera Degrader for the Treatment of <i>TRIM37</i>-Amplified Breast Cancer

Design, synthesis and biological evaluation of novel indolin-2-one derivatives as potent second-generation TRKs inhibitors

Design, synthesis, and biological evaluation of a potent PLK4 inhibitor WY29 with 1<i>H</i>‐pyrazolo[3,4‐<i>d</i>]pyrimidine scaffold

Discovery of CZS-241: A Potent, Selective, and Orally Available Polo-Like Kinase 4 Inhibitor for the Treatment of Chronic Myeloid Leukemia

Design, synthesis, and biological evaluation of potent FAK-degrading PROTACs

Identification of 1<i>H</i>-pyrazolo[3,4-b]pyridine derivatives as novel and potent TBK1 inhibitors: design, synthesis, biological evaluation, and molecular docking study

Structure-based discovery of 1-(3-fluoro-5-(5-(3-(methylsulfonyl)phenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)phenyl)-3-(pyrimidin-5-yl)urea as a potent and selective nanomolar type-II PLK4 inhibitor

Design, synthesis, and biological evaluation of novel pyrazolo [3,4-d]pyrimidine derivatives as potent PLK4 inhibitors for the treatment of TRIM37-amplified breast cancer

Discovery of quinazoline derivatives CZw-124 as a pan-TRK inhibitor with potent anticancer effects in vitro and in vivo

Collaborators (1)

Yuhsin Vivian Huang

Make your next move.